Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives

Clinical Microbiology Reviews
Fabiana AlvesJorge Alvar

Abstract

Research in visceral leishmaniasis in the last decade has been focused on how better to use the existing medicines as monotherapy or in combination. Systematic research by geographical regions has shown that a universal treatment is far from today's reality. Substantial progress has been made in the elimination of kala-azar in South Asia, with a clear strategy on first- and second-line therapy options of single-dose liposomal amphotericin B and a combination of paromomycin and miltefosine, respectively, among other interventions. In Eastern Africa, sodium stibogluconate (SSG) and paromomycin in combination offer an advantage compared to the previous SSG monotherapy, although not exempted of limitations, as this therapy requires 17 days of painful double injections and bears the risk of SSG-related cardiotoxicity. In this region, attempts to improve the combination therapy have been unsuccessful. However, pharmacokinetic studies have led to a better understanding of underlying mechanisms, like the underexposure of children to miltefosine treatment, and an improved regimen using an allometric dosage. Given this global scenario of progress and pitfalls, we here review what steps need to be taken with existing medicines and highlig...Continue Reading

References

Dec 1, 1986·Antimicrobial Agents and Chemotherapy·J D BermanG Lopez-Berestein
Mar 1, 1968·Annals of Tropical Medicine and Parasitology·R A Neal
May 1, 1996·Transactions of the Royal Society of Tropical Medicine and Hygiene·C P ThakurP Olliaro
Jun 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R N DavidsonA D Bryceson
Sep 24, 1999·Transactions of the Royal Society of Tropical Medicine and Hygiene·C P ThakurA Kumar
Sep 30, 1999·Parasitology·C R Davies, A S Mazloumi Gavgani
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S SundarH W Murray
May 24, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·E E Zijlstra, A M el-Hassan
Aug 9, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·P Desjeux
Nov 13, 2001·Tropical Medicine & International Health : TM & IH·A Bryceson
Jul 24, 2002·The American Journal of Tropical Medicine and Hygiene·S SundarR Buffels
Nov 29, 2002·The New England Journal of Medicine·Shyam SundarJonathan Berman
Feb 1, 2003·The Lancet Infectious Diseases·E E ZijlstraA M el-Hassan
Feb 21, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vassiliki SyriopoulouGeorge Saroglou
Mar 11, 2003·Annals of Tropical Medicine and Parasitology·A M MusaA M El Hassan
Apr 15, 2004·Australian Veterinary Journal·P C MillsS E Cross
Oct 27, 2004·Advances in Parasitology·Jorge AlvarJavier Nieto
Mar 24, 2006·Tropical Medicine & International Health : TM & IH·Simon M CollinRobert N Davidson
Aug 31, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Caryn BernJorge Alvar
Oct 7, 2006·Trends in Parasitology·Jorge AlvarCaryn Bern
Feb 15, 2007·African Journal of Health Sciences·Kevin M Wasunna
Jun 22, 2007·The New England Journal of Medicine·Shyam SundarSujit K Bhattacharya
Jul 13, 2007·The Journal of Infectious Diseases·Sujit Kumar BhattacharyaNirmal Kumar Ganguly
Oct 17, 2007·Nature Reviews. Microbiology·François ChappuisMarleen Boelaert
Apr 11, 2008·Clinical Microbiology Reviews·Jorge AlvarJavier Moreno
Sep 4, 2008·Tropical Medicine & International Health : TM & IH·Luigi GradoniJean-Claude Dujardin
Feb 12, 2010·The New England Journal of Medicine·Shyam SundarHenry W Murray
Feb 27, 2010·The Lancet Infectious Diseases·Johan van GriensvenMarleen Boelaert
Aug 5, 2010·The American Journal of Tropical Medicine and Hygiene·Prabhat K SinhaKrishna Pandey
Oct 27, 2010·Tropical Medicine & International Health : TM & IH·Jens Aagaard-HansenJorge Alvar
Nov 5, 2010·PLoS Neglected Tropical Diseases·Asrat HailuUNKNOWN Leishmaniasis East Africa Platform (LEAP) group
Mar 5, 2011·Journal of Vector Ecology : Journal of the Society for Vector Ecology·Dia-Eldin A Elnaiem
Apr 2, 2011·The Lancet Infectious Diseases·Greg MatlashewskiJorge Alvar
May 21, 2011·Trends in Parasitology·Michael O HarhayCarlos Henrique Nery Costa
Jul 8, 2011·The American Journal of Tropical Medicine and Hygiene·Mahmudur RahmanByron Arana
Dec 6, 2011·PLoS Neglected Tropical Diseases·Anette StauchHans-Peter Duerr

❮ Previous
Next ❯

Citations

Dec 5, 2018·Expert Review of Anti-infective Therapy·Temmy SunyotoFilip Meheus
Jan 24, 2019·BMJ : British Medical Journal·Suman RijalMarleen Boelaert
May 10, 2019·PLoS Neglected Tropical Diseases·Farhat AfrinHassan A Hemeg
Sep 2, 2019·Parasitology Research·Sarah HendrickxL Maes
Nov 5, 2019·Expert Opinion on Therapeutic Targets·Stanley C XieLeann Tilley
Feb 29, 2020·Expert Opinion on Drug Discovery·Li-Ming ZhouGuang-Fu Yang
Apr 5, 2020·Marine Drugs·María Álvarez-BardónRafael Balaña-Fouce
Sep 20, 2019·PLoS Neglected Tropical Diseases·Angamuthu SelvapandiyanNirmal K Ganguly
Feb 13, 2020·Parasitology·Claudio A PereiraEdward Valera-Vera
Jul 1, 2020·Antimicrobial Agents and Chemotherapy·M Van den KerkhofG Caljon
Jul 1, 2020·Microorganisms·Magali Van den KerkhofGuy Caljon
Jun 25, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Abdelhalim Babiker MahmoudPascal Mäser
Jul 6, 2019·Frontiers in Oncology·Maria E MycielskaEdward K Geissler
Nov 30, 2019·Frontiers in Cellular and Infection Microbiology·Eugenia Carrillo, Javier Moreno
Aug 23, 2019·Expert Opinion on Drug Delivery·Juliane S LanzaFrédéric Frézard
Mar 12, 2021·Frontiers in Cellular and Infection Microbiology·Srija MoulikMitali Chatterjee
Mar 23, 2021·Frontiers in Cellular and Infection Microbiology·Marianne Rocha-HaslerPascal Mäser
Mar 31, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Brima M YounisAhmed M Musa
Feb 14, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Luka VerrestThomas P C Dorlo
May 5, 2021·Journal of Medicinal Chemistry·Alejandro RevueltoSonsoles Velázquez
May 21, 2021·International Journal for Parasitology. Drugs and Drug Resistance·Myriam GonzálezRafael Peláez
Jun 5, 2021·RSC Medicinal Chemistry·Paul J KoovitsLuiz C Dias
Jul 1, 2021·Research and Reports in Tropical Medicine·Grace GriffertyRichard Wamai
Aug 7, 2021·Journal of Medicinal Chemistry·Jared T HammillR Kiplin Guy
May 12, 2020·Journal of Medicinal Chemistry·Victoriano Corpas-LópezJosé A Gómez-Vidal
Jul 20, 2019·International Journal for Parasitology. Drugs and Drug Resistance·Diana CaridhaSimon L Croft
Oct 30, 2021·Journal of Medicinal Chemistry·Charles E MowbraySusan Wyllie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.